Ataxia in mitochondrial disorders

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 359-372

  Zeviani, Massimo ^a   Simonati, Alessandro ^b   Bindoff, Laurence A ^c  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961155770     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00022-X     Document Type: Chapter

References (101)

1. Allikmets R., Raskind W.H., Hutchinson A., et al. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (KLSA/A). Hum Mol Genet 1999, 8:743-749.
2. Anderson S., Bankier A.T., Barrel B.G., et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290:457-465.
3. Austin S.A., Vriesendorp F.J., Thandroyen F.T., et al. Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation. Neurology 1998, 51:1447-1450.
4. Bardosi A., Creutzfeld W., DiMauro S., et al. Myo-neuro-gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome c oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 1987, 74:248-258.
5. Barkovich A., Good W., Koch T., et al. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993, 14:1119-1137.
6. Berkovic S.F., Carpenter S., Evans A., et al. Myoclonus epilepsy and ragged-red fibres (MERRF): a clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989, 112:1231-1260.
7. Berkovic S.F., Cochius J., Andermann E., et al. Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia 1993, 34:S19-S30.
8. Bindoff L.A., Birch-Machin M.A., Farnsworth L., et al. Familial intermittent ataxia due to a defect of the E1 component of pyruvate dehydrogenase complex. J Neurol Sci 1989, 93:311-318.
9. Boitier E., Degoul F., Desguerre I., et al. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 1998, 156:41-46.
10. Bourgeron T., Rustin P., Chretien D., et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995, 11:144-149.
11. Bugiani M., Invernizzi F., Alberio S., et al. Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 2004, 1659:136-147.
12. Bugiani M., Tiranti V., Farina L., et al. Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency. J Med Genet 2005, 42:e28.
13. Bykhovskaya Y., Casas K., Mengesha E., et al. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 2004, 74:1303-1308.
14. Campuzano V., Montermini L., Molto M.D., et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1426-1427.
15. Casari G., De Fusco M., Ciamartori S., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloproteinase. Cell 1998, 93:973-983.
16. Chinnery P.F., DiMauro S., Shanske S., et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004, 364:592-596.
17. Craig K., Elliott H.R., Keers S.M., et al. Episodic ataxia and hemiplegia caused by the 8993T->C mitochondrial DNA mutation. J Med Genet 2007, 44:797-799.
18. De Vries D.D., van Engelen B.G., Gabreels F.J., et al. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993, 34:410-412.
19. DiMauro S., Schon E.A. Mitochondrial disorders in the nervous system. Ann Rev Neurosci 2008, 31:91-123.
20. Dionisi-Vici C., Seneca S., Zeviani M., et al. Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene. J Inherit Metab Dis 1998, 21:2-8.
21. Elpeleg O. Inherited mitochondrial DNA depletion. Pediatr Res 2003, 54:153-159.
22. Fadic R., Russell J.A., Vedanarayanan V.V., et al. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997, 49:239-245.
23. Ferrari G., Lamantea E., Donati A., et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005, 128:723-731.
24. Franceschetti S., Antozzi C., Binelli S., et al. Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol Scand 1993, 87:219-223.
25. Fukuhara N. MERRF: a clinicopathological study. Relationships between myoclonus epilepsies and mitochondrial myopathies. Rev Neurol (Paris) 1991, 147:476-479.
26. Fukuhara N., Tokiguchi S., Shirakawa K., et al. Myoclonus epilepsy associated with ragged red fibres (mitochondrial abnormalities): disease entity or a syndrome?. J Neurol Sci 1980, 47:117-133.
27. Goto Y., Nonaka I., Horai S. A mutation in trnaleu(UUR) gene associated with MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990, 348:651-653.
28. Hakonen A.H., Heiskanen S., Juvonen V., et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005, 77:430-441.
29. Hammans S.R., Sweeney M.G., Brockington M., et al. The mitochondrial DNA transfer RNA(Lys)A->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993, 116:617-632.
30. Hirano M., Ricci E., Koenigsberger R., et al. MELAS: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992, 2:125-135.
31. Hirano M., Silvestri G., Blake D.M., et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994, 44:721-727.
32. Hirano M., Lagier-Tourenne C., Valentino M.L., et al. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 2005, 354:152-156.
33. Holt I.J., Harding A.E., Petty R.H.K., et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990, 46:428-433.
34. Howell N., Kubacka I., Smith R., et al. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 1996, 46:219-222.
35. Hudson G., Deschauer M., Busse K., et al. Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 2005, 64:371-373.
36. Jackson M.J., Schaefer J., Johnson M.A., et al. Presentation and clinical investigation of mitochondrial (respiratory chain) disease: a study of 51 patients. Brain 1995, 118:339-357.
37. Jin H., May M., Tranebjaerg L., et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996, 14:177-180.
38. Koehler C.M., Leuenberger D., Merchant S., et al. Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci U S A 1999, 96:2141-2146.
39. Lagier-Tourenne C., Tazir M., López L.C., et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 2008, 82:661-672.
40. Lamantea E., Tiranti V., Bordoni A., et al. Mutations of mitochondrial DNA polymerase gammaa are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 2002, 52:211-219.
41. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951, 14:216-221.
42. Lombes A., Mendell J.R., Nakase H., et al. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol 1989, 26:20-33.
43. Lonnqvist T., Paetau A., Nikali K., et al. Infantile onset spinocerebellar ataxia with sensory neuropathy (IOSCA): neuropathological features. J Neurol Sci 1998, 161:57-65.
44. Mandel H., Szargel R., Labay V., et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001, 29:337-341.
45. Nat Genet 2001, 29:491. Erratum in:.
46. McKelvie P.A., Morley J.B., Byrne E., et al. Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNA. J Neurol Sci 1991, 102:51-60.
47. Medina L., Chi T.L., DeVivo D.C., et al. MR findings inpatients with subacute necrotizing encephalomyopathy (Leigh syndrome): correlation with biochemical defect. AJNR Am J Neuroradiol 1990, 11:379-384.
48. Mizukami K., Sasaki M., Suzuki T., et al. Central nervous system changes in mitochondrial encephalomyopathy: a light and electron microscopic study. Acta Neuropathol (Berl) 1992, 83:449-452.
49. Moraes C.T., DiMauro S., Zeviani M., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989, 320:1293-1299.
50. Moraes C.T., Shanske S., Tritschler H.J., et al. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991, 48:492-501.
51. Musumeci O., Naini A., Slonim A.E., et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 2001, 56:849-855.
52. Naviaux R.K., Nguyen K.V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004, 55:706-712.
53. Nijtmans M.G., Hammans S.R., Duchen L.W., et al. Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci 1994, 121:57-65.
54. Nishigaki Y., Marti R., Copeland W.C., et al. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 2003, 111:1913-1921.
55. Nishino I., Spinazzola A., Hirano M. Thymidine phosphorylation gene mutations in MNGIE, a human mitochondrial disorder. Science 1999, 283:689-692.
56. Ogasahara S., Engel A.G., Frens D., et al. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A 1989, 86:2379-2382.
57. Oldfors A., Fyhr I.M., Holme E., et al. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol (Berl) 1990, 80:541-546.
58. Oldfors A., Holme E., Tulinius M., et al. Tissue distribution and disease manifestations of the trna(Lys) A->G(8344) mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol (Berl) 1995, 90:328-333.
59. Poulton J., Morten K., Weber K., et al. Are duplications of mitochondrial DNA characteristic of Kearns-Sayre syndrome?. Hum Mol Genet 1994, 3:947-951.
60. Rantamaki M., Krahe R., Paetau A., et al. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. Neurology 2001, 57:1043-1049.
61. Rosing H.S., Hopkins L.C., Wallace D.C., et al. Maternally inherited mitochondrial myopathy and myoclonic epilepsy. Ann Neurol 1985, 17:228-237.
62. Rotig A., Appelkvist E.L., Geromel V., et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 2000, 356:391-395.
63. Rustin P., Rotig A. Inborn errors of complex II - unusual human mitochondrial diseases. Biochim Biophys Acta 2002, 1553:117-122.
64. Saada A., Shaag A., Mandel H., et al. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001, 29:342-344.
65. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999, 283:1488-1493.
66. Savoiardo M., Uziel G., Strada L., et al. MRI findings in Leigh's disease with cytochrome-c-oxidase deficiency. Neuroradiology 1991, 33:507-508.
67. Savoiardo M., Bruzzone M.G., D'Incerti L., et al. Metabolic and genetic diseases of the brain. Rivista di Neuroradiologia 1999, 12:73-86.
68. Schuelke M., Smeitink J., Mariman E., et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999, 21:260-261.
69. Sciacco M., Prelle A., D'Adda E., et al. Familial mtDNA T8993C transition causing both the NARP and the MILS phenotype in the same generation. A morphological, genetic and spectroscopic study. J Neurol 2003, 250:1498-1500.
70. Shoffner J.M., Lott M.T., Lezza A.M.S., et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA trnalys mutation. Cell 1990, 61:931-937.
71. Silvestri G., Moraes C.T., Shanske S., et al. A new mtDNA mutation the trnalys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992, 51:1213-1217.
72. Silvestri G., Ciafaloni E., Santorelli F.M., et al. Clinical features associated with the A->G transition at nucleotide 8344 of mtDNA ('MERRF' mutation). Neurology 1993, 43:1200-1206.
73. Simonati A., Filosto M., Tomelleri G., et al. Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease. J Neurol 2003, 250:702-706.
74. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2001, 2:342-352.
75. Smeitink L.J., Triepels R., Smeets T., et al. The first nuclear encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998, 63:1598-1608.
76. Sobreira C., Hirano M., Shanske S., et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 1997, 48:1238-1243.
77. Spinazzola A., Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005, 354:162-168.
78. Suomalainen A., Majander A., Wallin M., et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 1997, 48:1244-1253.
79. Tanji K., Vu T.H., Schon E.A., et al. Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol 1999, 45:377-383.
80. Tatuch Y., Christodoulou J., Feigenbaum A., et al. Heteroplasmic mtDNA mutation (T->G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992, 50:852-858.
81. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005, 6:389-402.
82. Thyagarajan D., Shanske S., Vazquez-Memije M., et al. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995, 38:468-472.
83. Tiranti V., Hoertnagel K., Carrozzo R., et al. Mutations in SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998, 63:1609-1621.
84. Triepels R.H., van den Heuvel L.P., Loeffen J.L.C.M., et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol 1999, 45:787-790.
85. Tritschler H.J., Andreetta F., Moraes C.T., et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992, 42:209-217.
86. Tsuchiya K., Miyazaki H., Akabane H., et al. MELAS with prominent white matter gliosis and atrophy of the cerebellar granular layer: a clinical, genetic, and pathological study. Acta Neuropathol (Berl) 1999, 97:520-524.
87. Uziel G., Moroni I., Lamantea E., et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical and molecular study in six families. J Neurol Neurosurg Psychiatry 1997, 63:16-22.
88. Valanne L., Ketonen L., Majander A., et al. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998, 19:369-377.
89. Van Goethem G., Dermaut B., Lofgren A., et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001, 28:211-212.
90. Van Goethem G., Martin J.J., Dermaut B., et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 2003, 13:133-142.
91. Van Goethem G., Luoma P., Rantamaki M., et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 2004, 63:1251-1257.
92. Van Maldergem L., Trijbels F., DiMauro S., et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 2002, 52:750-754.
93. Visapaa I., Fellman V., Vesa J., et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 2002, 71:863-876.
94. Wallace D.C., Zheng X., Lott M., et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988, 55:601-610.
95. Winterthun S., Ferrari G., He L., et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 2005, 64:1204-1208.
96. Zeviani M., Di Donato S. Mitochondrial disorders. Brain 2004, 127:2153-2172.
97. Brain 2004, 127:2783. Erratum in:.
98. Zeviani M., Moraes C.T., DiMauro S., et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988, 38:1339-1346.
99. Zeviani M., Muntoni F., Savarese N., et al. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNALyS gene. Eur J Hum Genet 1993, 1:80-87.
100. Zeviani M., Amati P., Comi G., et al. Searching for genes affecting the structural integrity of the mitochondrial genome. Biochim Biophys Acta 1995, 1271:153-158.
101. Zhu Z., Yao J., Johns T., et al. Surf 1, a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998, 20:337-343.